• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人纤溶酶原激活物抑制剂1(PAI-1)在噬菌体上的功能展示:通过易错DNA合成进行结构-功能分析的新视角

Functional display of human plasminogen-activator inhibitor 1 (PAI-1) on phages: novel perspectives for structure-function analysis by error-prone DNA synthesis.

作者信息

Pannekoek H, van Meijer M, Schleef R R, Loskutoff D J, Barbas C F

机构信息

Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Department of Molecular Biology, Amsterdam.

出版信息

Gene. 1993 Jun 15;128(1):135-40. doi: 10.1016/0378-1119(93)90164-x.

DOI:10.1016/0378-1119(93)90164-x
PMID:8508955
Abstract

The synthesis of the human plasminogen-activator inhibitor 1 (PAI-1) protein in the cytoplasm of transformed Escherichia coli cells results in inactive protein preparations that can be activated by denaturation and renaturation. We have used the phagemid pComb3, designed for combinatorial immunoglobulin repertoire cloning, for routing of PAI-1 to the periplasm and subsequent exposure on the surface of filamentous phages. Phage-displayed PAI-1 specifically binds to immobilized polyclonal and monoclonal anti-human PAI-1 antibodies. In addition, PAI-1 retains its capacity to form equimolar complexes with its target serine protease tissue-type plasminogen activator (t-PA), as well as its ability to inhibit t-PA activity. Finally, we have explored and manipulated the error-prone property of TaqI DNA polymerase during PCR amplification of the full-length PAI-1 cDNA to generate a large library of predominantly single, random PAI-1 mutants. In addition, a computer simulation program has been devised that converts the number of mutations per codogenic region (in this case PAI-1) into actual mutant proteins. The PAI-1-phage mutant library is composed of 46% single and 34% double mutants and 20% wild-type PAI-1 and can be employed to isolate mutants defective in interactions of PAI-1 with other components. The method described here is applicable to other studies on the structure-function analysis of eukaryotic proteins.

摘要

在转化的大肠杆菌细胞胞质中合成的人纤溶酶原激活物抑制剂1(PAI-1)蛋白会产生无活性的蛋白制剂,这些制剂可通过变性和复性来激活。我们使用了为组合免疫球蛋白库克隆设计的噬菌粒pComb3,将PAI-1转运到周质并随后展示在丝状噬菌体表面。噬菌体展示的PAI-1特异性结合固定化的多克隆和单克隆抗人PAI-1抗体。此外,PAI-1保留了与靶丝氨酸蛋白酶组织型纤溶酶原激活剂(t-PA)形成等摩尔复合物的能力,以及抑制t-PA活性的能力。最后,我们在全长PAI-1 cDNA的PCR扩增过程中探索并利用了TaqI DNA聚合酶的易错特性,以生成一个主要由单个随机PAI-1突变体组成的大型文库。此外,还设计了一个计算机模拟程序,可将每个编码区(在本例中为PAI-1)的突变数转化为实际的突变蛋白。PAI-1噬菌体突变体文库由46%的单突变体、34%的双突变体和20%的野生型PAI-1组成,可用于分离PAI-1与其他成分相互作用缺陷的突变体。本文所述方法适用于其他关于真核蛋白结构-功能分析的研究。

相似文献

1
Functional display of human plasminogen-activator inhibitor 1 (PAI-1) on phages: novel perspectives for structure-function analysis by error-prone DNA synthesis.人纤溶酶原激活物抑制剂1(PAI-1)在噬菌体上的功能展示:通过易错DNA合成进行结构-功能分析的新视角
Gene. 1993 Jun 15;128(1):135-40. doi: 10.1016/0378-1119(93)90164-x.
2
Selective screening of a large phage display library of plasminogen activator inhibitor 1 mutants to localize interaction sites with either thrombin or the variable region 1 of tissue-type plasminogen activator.对纤溶酶原激活物抑制剂1突变体的大型噬菌体展示文库进行选择性筛选,以定位与凝血酶或组织型纤溶酶原激活物可变区1的相互作用位点。
J Biol Chem. 1996 Mar 29;271(13):7423-8. doi: 10.1074/jbc.271.13.7423.
3
High-density mutagenesis by combined DNA shuffling and phage display to assign essential amino acid residues in protein-protein interactions: application to study structure-function of plasminogen activation inhibitor 1 (PAI-I).通过DNA改组和噬菌体展示相结合进行高密度诱变以确定蛋白质-蛋白质相互作用中的必需氨基酸残基:应用于纤溶酶原激活抑制剂1(PAI-1)的结构-功能研究
J Mol Biol. 2000 Sep 1;301(5):1135-47. doi: 10.1006/jmbi.2000.4035.
4
Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.纤溶酶原激活物抑制剂1含有一个隐蔽的高亲和力受体结合位点,该位点在与组织型纤溶酶原激活物形成复合物时暴露出来。
Thromb Haemost. 1998 Nov;80(5):822-8.
5
Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.噬菌体展示的高突变纤溶酶原激活物抑制剂1(PAI-1)文库证明,潜伏期转变和蛋白酶抑制过程中PAI-1的不同结构要求。
J Mol Biol. 2001 Jan 26;305(4):773-83. doi: 10.1006/jmbi.2000.4356.
6
High level expression of recombinant plasminogen activator inhibitor-1 in Escherichia coli and generation of its mutants involving Asp125, Glu128 and Glu130.重组纤溶酶原激活物抑制剂-1在大肠杆菌中的高水平表达及其涉及Asp125、Glu128和Glu130的突变体的产生。
Biochem Mol Biol Int. 1997 Jul;42(3):621-9. doi: 10.1080/15216549700203031.
7
Engineering plasminogen activator inhibitor 1 mutants with increased functional stability.构建具有更高功能稳定性的纤溶酶原激活物抑制剂1突变体。
Biochemistry. 1994 Mar 29;33(12):3643-8. doi: 10.1021/bi00178a022.
8
Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Eur J Biochem. 1989 Dec 22;186(3):523-33. doi: 10.1111/j.1432-1033.1989.tb15238.x.
9
Selection of peptides that bind to plasminogen activator inhibitor 1 (PAI-1) using random peptide phage-display libraries.利用随机肽噬菌体展示文库筛选与纤溶酶原激活物抑制剂1(PAI-1)结合的肽段。
FEBS Lett. 1998 Jul 17;431(2):170-4. doi: 10.1016/s0014-5793(98)00742-x.
10
High-level synthesis of biologically active human plasminogen activator inhibitor type 1 (PAI-1) in Escherichia coli.在大肠杆菌中高效合成具有生物活性的人1型纤溶酶原激活物抑制剂(PAI-1)。
Gene. 1990 Dec 15;96(2):305-9. doi: 10.1016/0378-1119(90)90269-w.

引用本文的文献

1
Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape.深突变扫描纤溶酶原激活物抑制剂-1 的功能图谱。
Sci Rep. 2021 Sep 22;11(1):18827. doi: 10.1038/s41598-021-97871-7.
2
Identification of an alpha-1 antitrypsin variant with enhanced specificity for factor XIa by phage display, bacterial expression, and combinatorial mutagenesis.通过噬菌体展示、细菌表达和组合突变技术鉴定一种对因子 XIa 具有增强特异性的 alpha-1 抗胰蛋白酶变异体。
Sci Rep. 2021 Mar 10;11(1):5565. doi: 10.1038/s41598-021-84618-7.
3
Phage display of the serpin alpha-1 proteinase inhibitor randomized at consecutive residues in the reactive centre loop and biopanned with or without thrombin.
噬菌体展示技术在反应中心环的连续残基处对丝氨酸蛋白酶抑制剂α-1 进行随机化,并与或不与凝血酶进行生物淘选。
PLoS One. 2014 Jan 10;9(1):e84491. doi: 10.1371/journal.pone.0084491. eCollection 2014.
4
Functional display of proteins, mutant proteins, fragments of proteins and peptides on the surface of filamentous (bacterio) phages: A review.丝状(细菌)噬菌体表面蛋白质、突变体蛋白质、蛋白质片段和肽的功能展示:综述。
Cytotechnology. 1995 Jan;18(1-2):107-12. doi: 10.1007/BF00744325.
5
Display technologies: application for the discovery of drug and gene delivery agents.显示技术:在药物和基因递送剂发现中的应用
Adv Drug Deliv Rev. 2006 Dec 30;58(15):1622-54. doi: 10.1016/j.addr.2006.09.018. Epub 2006 Oct 6.
6
The basic structure of filamentous phage and its use in the display of combinatorial peptide libraries.丝状噬菌体的基本结构及其在组合肽库展示中的应用。
Mol Biotechnol. 1999 Sep;12(2):143-8. doi: 10.1385/MB:12:2:143.
7
Selection of proteins and peptides from libraries displayed on filamentous bacteriophage.
Mol Biotechnol. 1996 Oct;6(2):155-62. doi: 10.1007/BF02740770.
8
Phage display of enzymes and in vitro selection for catalytic activity.酶的噬菌体展示及催化活性的体外筛选
Appl Biochem Biotechnol. 1994 May-Jun;47(2-3):175-89; discussion 189-90. doi: 10.1007/BF02787933.
9
Protein-protein interactions: methods for detection and analysis.蛋白质-蛋白质相互作用:检测与分析方法
Microbiol Rev. 1995 Mar;59(1):94-123. doi: 10.1128/mr.59.1.94-123.1995.